Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

The calpain/calpastatin system has opposing roles in growth and metastatic dissemination of melanoma.

Raimbourg Q, Perez J, Vandermeersch S, Prignon A, Hanouna G, Haymann JP, Baud L, Letavernier E.

PLoS One. 2013;8(4):e60469. doi: 10.1371/journal.pone.0060469. Epub 2013 Apr 2.

2.

Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.

Wang Y, Zheng D, Wei M, Ma J, Yu Y, Chen R, Lacefield JC, Xu H, Peng T.

Cardiovasc Res. 2013 Jun 1;98(3):381-90. doi: 10.1093/cvr/cvt048. Epub 2013 Mar 1.

PMID:
23455548
3.

Critical role of the calpain/calpastatin balance in acute allograft rejection.

Letavernier E, Dansou B, Lochner M, Perez J, Bellocq A, Lindenmeyer MT, Cohen CD, Haymann JP, Eberl G, Baud L.

Eur J Immunol. 2011 Feb;41(2):473-84. doi: 10.1002/eji.201040437. Epub 2010 Dec 23.

4.

Extracellular Calpain/Calpastatin Balance Is Involved in the Progression of Pulmonary Hypertension.

Wan F, Letavernier E, Abid S, Houssaini A, Czibik G, Marcos E, Rideau D, Parpaleix A, Lipskaia L, Amsellem V, Gellen B, Sawaki D, Derumeaux G, Dubois-Randé JL, Delcroix M, Quarck R, Baud L, Adnot S.

Am J Respir Cell Mol Biol. 2016 Sep;55(3):337-51. doi: 10.1165/rcmb.2015-0257OC.

PMID:
26974350
5.

Trichostatin A epigenetically increases calpastatin expression and inhibits calpain activity and calcium-induced SH-SY5Y neuronal cell toxicity.

Seo J, Jo SA, Hwang S, Byun CJ, Lee HJ, Cho DH, Kim D, Koh YH, Jo I.

FEBS J. 2013 Dec;280(24):6691-701. doi: 10.1111/febs.12572. Epub 2013 Nov 7.

6.

The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells.

Murray SS, Grisanti MS, Bentley GV, Kahn AJ, Urist MR, Murray EJ.

Exp Cell Res. 1997 Jun 15;233(2):297-309.

PMID:
9194492
7.

Over-expression of calpastatin inhibits calpain activation and attenuates myocardial dysfunction during endotoxaemia.

Li X, Li Y, Shan L, Shen E, Chen R, Peng T.

Cardiovasc Res. 2009 Jul 1;83(1):72-9. doi: 10.1093/cvr/cvp100. Epub 2009 Mar 24.

PMID:
19318376
8.

Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.

Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro Keller A, Haymann JP, Baud L.

Circ Res. 2008 Mar 28;102(6):720-8. doi: 10.1161/CIRCRESAHA.107.160077. Epub 2008 Feb 7.

9.

Decreased expression of calpain and calpastatin mRNA during development is highly correlated with muscle protein accumulation in neonatal pigs.

Li Z, Cao B, Zhao B, Yang X, Fan MZ, Yang J.

Comp Biochem Physiol A Mol Integr Physiol. 2009 Apr;152(4):498-503. doi: 10.1016/j.cbpa.2008.12.004. Epub 2008 Dec 13.

PMID:
19130893
10.

Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.

Vaisid T, Kosower NS, Katzav A, Chapman J, Barnoy S.

Neurochem Int. 2007 Nov-Dec;51(6-7):391-7. Epub 2007 Apr 19.

PMID:
17513017
12.

Calpains contribute to vascular repair in rapidly progressive form of glomerulonephritis: potential role of their externalization.

Letavernier B, Zafrani L, Nassar D, Perez J, Levi C, Bellocq A, Mesnard L, Sachon E, Haymann JP, Aractingi S, Faussat AM, Baud L, Letavernier E.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):335-42. doi: 10.1161/ATVBAHA.111.240242. Epub 2011 Nov 17.

13.

Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injury.

Schoch KM, Evans HN, Brelsfoard JM, Madathil SK, Takano J, Saido TC, Saatman KE.

Exp Neurol. 2012 Aug;236(2):371-82. doi: 10.1016/j.expneurol.2012.04.022. Epub 2012 May 1.

14.

Induction of apoptosis in Eμ-myc lymphoma cells in vitro and in vivo through calpain inhibition.

Li H, Nepal RM, Martin A, Berger SA.

Exp Hematol. 2012 Jul;40(7):548-563.e2. doi: 10.1016/j.exphem.2012.02.002. Epub 2012 Feb 23.

PMID:
22366408
15.

Characterization of the calcium-dependent proteolytic system in a mouse muscle cell line.

Dargelos E, Dedieu S, Moyen C, Poussard S, Veschambre P, Brustis JJ, Cottin P.

Mol Cell Biochem. 2002 Feb;231(1-2):147-54.

PMID:
11952156
16.

Intracellular regulatory system involving calpain and calpastatin.

Murachi T.

Biochem Int. 1989 Feb;18(2):263-94. Review.

PMID:
2548504
17.

Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis.

Stifanese R, Averna M, De Tullio R, Pedrazzi M, Beccaria F, Salamino F, Milanese M, Bonanno G, Pontremoli S, Melloni E.

J Biol Chem. 2010 Jan 1;285(1):631-43. doi: 10.1074/jbc.M109.031674. Epub 2009 Oct 30.

18.

Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains.

Moldoveanu T, Gehring K, Green DR.

Nature. 2008 Nov 20;456(7220):404-8. doi: 10.1038/nature07353.

19.

Identification of mu-, m-calpains and calpastatin and capture of mu-calpain activation in endothelial cells.

Fujitani K, Kambayashi J, Sakon M, Ohmi SI, Kawashima S, Yukawa M, Yano Y, Miyoshi H, Ikeda M, Shinoki N, Monden M.

J Cell Biochem. 1997 Aug 1;66(2):197-209.

PMID:
9213221
20.

Calpastatin overexpression impairs postinfarct scar healing in mice by compromising reparative immune cell recruitment and activation.

Wan F, Letavernier E, Le Saux CJ, Houssaini A, Abid S, Czibik G, Sawaki D, Marcos E, Dubois-Rande JL, Baud L, Adnot S, Derumeaux G, Gellen B.

Am J Physiol Heart Circ Physiol. 2015 Dec 1;309(11):H1883-93. doi: 10.1152/ajpheart.00594.2015. Epub 2015 Oct 9.

Supplemental Content

Support Center